Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Initiation of Lantus® Leads to Better Glycemic Control at Similar Weight Gain Versus Other Comparators in Patients With Type 2 Diabetes
Date:9/12/2011
cs, therapies, services, and devices. Sanofi markets both injectable and oral medications for people with type 1 or type 2 diabetes. Investigational compounds in the pipeline include an injectable GLP-1 agonist being studied as a single agent, in combination with basal insulins, and/or in combination with oral antidiabetic agents.
About Sanofi Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Forward Looking Statements This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects", "anticipates", "believes", "intends", "estimates", "plans" and similar expressions. Although Sanofi's management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by,
'/>"/>
| SOURCE Sanofi Copyright©2010 PR Newswire. All rights reserved |
Related medicine technology :
1. Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
2. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
3. Alder Biopharmaceuticals to Receive $15 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6
4. A Recent Study by ITGs Majestic Market Research Indicates a Strong Launch for Gilenya in Spite of Its Time-Consuming Initiation Process
5. Initiation of Antiretroviral Treatment Protects Uninfected Sexual Partners from HIV Infection (HPTN Study 052)
6. Initiation of FLINT Announced by NIDDK: Study of Intercept Pharmaceuticals Obeticholic Acid (INT-747) in NASH
7. Genus Oncology, LLC Announces Initiation of Phase I Trial of GO-203-2c in Patients With Solid Tumors
8. Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
9. Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer
10. Upsher-Smith Laboratories Announces Initiation of Open-Label Extension Study of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
11. Amira Pharmaceuticals Announces Initiation of Phase I Clinical Trial for AM152, A Novel LPA1 Antagonist
Post Your Comments:
(Date:5/21/2013)... The North Shore-LIJ Health System is expanding a ... at North Shore University Hospital in Manhasset, ... at Forest Hills (NY) Hospital. ... new pilot program strengthens patient safety by providing hospitals ... first time in the US that remote video auditing ...
(Date:5/21/2013)... -- Vasomedical, Inc. (OTC BB: VASO) (the "Company"), a diversified medical ... medical devices and in the domestic sale of diagnostic imaging ... , President and CEO of Vasomedical, Inc. will present at ... 30, 2013 in New York City ... presentation is scheduled to begin at 9:30 a.m. EDT. ...
(Date:5/21/2013)... BioElectronics Corp. (PINKSHEETS: BIEL), the maker ... that CEO, Andrew J. Whelan ... Advisory Committee, Orthopedic and Rehabilitation Panel compelling arguments ... counter sales. "It,s been 37 years ... schema," Whelan said. "While the old classification of ...
Breaking Medicine Technology:North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3... N.J., Jan. 24, 2012 Watson Pharmaceuticals, Inc. (NYSE: ... earnings per share of $4.75-$4.77, a 39 percent increase ... Investor Meeting in New York City. Excluding the November ... represent a $0.64 earnings contribution, earnings grew at approximately ...
... 2012 Researchers at the University of Michigan analyzed the ... less expensive, more effective tests are less likely to ... neuropathy diagnoses undergo high-cost, low-yield MRIs while very few ... study that will be published Jan. 23 in the ...
Cached Medicine Technology:Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77 2Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77 3Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77 4Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77 5Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77 6Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77 7Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77 8Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77 9Neuropathy Patients More Likely to Receive High-cost, Low-yield Screening Instead of More Effective Tests 2Neuropathy Patients More Likely to Receive High-cost, Low-yield Screening Instead of More Effective Tests 3(Date:5/21/2013)... , , MONDAY, May 20 (HealthDay News) -- Young drivers ... higher risk of getting into car crashes, but Australian ... sleep on weekends puts them in even greater danger ... another challenge to adolescents that comes with lack of ... of the Center for Injury Research and Prevention at ...
(Date:5/21/2013)... , , MONDAY, May 20 (HealthDay News) -- Long-acting ... chronic obstructive pulmonary disease (COPD) may raise the ... new large Canadian study reveals. The finding ... prescribed long-acting bronchodilators -- either anticholinergics (such as ... are commonly used to relieve the shortness of ...
(Date:5/21/2013)... TUESDAY, May 21 (HealthDay News) -- Thousands of ... from the lung condition known as chronic obstructive ... that patients placed on the common antibiotic azithromycin ... due to flare-ups of the disease. "Given ... of such events is critical," said Victoria Richards, ...
(Date:5/21/2013)... (HealthDay News) -- Racial disparities exist in the treatment ... United States, according to a large new study. ... part of their initial treatment, researchers found that blacks ... surgery in the early stages of the disease. Hispanics ... and stage 2 disease than white patients. "In ...
(Date:5/21/2013)... The surgical management of non-small cell lung cancer ... race of the patient, according to a new study., ... and Stage II NSCLC is surgery," said researcher Jayanth ... Omaha, Nebraska. "In our study of more than 1,200,000 ... years 2000 and 2010, we found statistically significant racial ...
Breaking Medicine News(10 mins):Health News:Weekend 'Catch-Up' Sleep May Cut Young Drivers' Crash Risk 2Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 2Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 3Health News:Long-Term Use of Antibiotic May Help Those With COPD 2Health News:Long-Term Use of Antibiotic May Help Those With COPD 3Health News:Racial Disparities Seen in U.S. Lung Cancer Treatment 2[0] Weekend 'Catch-Up' Sleep May Cut Young Drivers' Crash Risk[0] Certain COPD Meds Might Raise Heart Risks, Study Says[0] Long-Term Use of Antibiotic May Help Those With COPD[0] Racial Disparities Seen in U.S. Lung Cancer Treatment[0] Racial disparities in the surgical management of non-small cell lung cancer
... The first results of the first European survey of cancer ... 6th congress of the European Federation of Chapters of the ... surveys have looked at the overall management of pain in ... look in detail at Breakthrough Cancer Pain (BTCP) from a ...
... ... Proactive Wellness Centers, PLC -- a leading Anti-Aging Practice, is the featured speaker at ... in Northern Virginia. , ... Sterling, VA (PRWEB) September 11, 2009 -- Most women understand that health factors ...
... ... specialist Flintec has recruited eight new software and electronic developers to ... equipment is Flintec,s fastest growing area of business. Increasing numbers of ... build the precision measuring systems at the heart of their life-saving ...
... , , NEW YORK, Sept. ... and The Mount Sinai Medical Center describe the Community Diabetes ... outreach program which was designed specifically for people from the vulnerable ... Twenty-five patients from The Mount Sinai Medical Center were randomly ...
... , , , ... industry leader, declared his support for H.R. 1891, a House bill ... deduction. Roeser is Senior Vice President of Marketing and Operations for ... -- one of the nation,s largest and most experienced long-term care ...
... , VOORHEES, N.J., Sept. 10 Angioedema is ... organs, and airway, causing discomfort and even death as a result ... the prevention and treatment of angioedema, and new therapies are being ... patient population. , , To address the need ...
Cached Medicine News:Health News:First results from major European patient survey show devastating impact of living with breakthrough cancer pain 2Health News:Dr. Lynese Lawson Speaks to Sterling Women: Strategies to Rejuvenate Your Health and Your Career 2Health News:Dr. Lynese Lawson Speaks to Sterling Women: Strategies to Rejuvenate Your Health and Your Career 3Health News:Flintec Load Cell Design Helps to Create Vital Medical Solutions 2Health News:Flintec Load Cell Design Helps to Create Vital Medical Solutions 3Health News:Flintec Load Cell Design Helps to Create Vital Medical Solutions 4Health News:Dr. Eliscer Guzman, with The Mount Sinai Medical Center, Join Forces to Celebrate the Community Diabetes and Cardiovascular Care Program's Graduation Ceremony on September 16th 2Health News:Industry Leader Praises Health Reform Bill that Provides 50% Tax Deduction for Long-Term Care Premiums 2Health News:New Directions in Angioedema: A Focus on Supportive Care and Treatment Options 2First results from major European patient survey show devastating impact of living with breakthrough cancer painDr. Lynese Lawson Speaks to Sterling Women: Strategies to Rejuvenate Your Health and Your CareerFlintec Load Cell Design Helps to Create Vital Medical SolutionsDr. Eliscer Guzman, with The Mount Sinai Medical Center, Join Forces to Celebrate the Community Diabetes and Cardiovascular Care Program's Graduation Ceremony on September 16thIndustry Leader Praises Health Reform Bill that Provides 50% Tax Deduction for Long-Term Care PremiumsNew Directions in Angioedema: A Focus on Supportive Care and Treatment Options
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |